Filing Details

Accession Number:
0001171843-12-001173
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-06 06:10:51
Reporting Period:
2012-04-04
Filing Date:
2012-04-06
Accepted Time:
2012-04-06 06:10:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1318641 Cleveland Biolabs Inc CBLI Services-Commercial Physical & Biological Research (8731) 200077155
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1523106 C David Hohn C/O Cleveland Biolabs, Inc.
73 High Street
Buffalo NY 14203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.005 Per Share Acquisiton 2012-04-04 1,000 $1.71 3,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2011.